Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1

References

• Dinkova-Kostova AT, Talalay P. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic Biol Med 2000;29:231–40
   PubMed Web of Science ®Google Scholar
• Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 1995;49:127–40
   PubMed Web of Science ®Google Scholar
• Ross D, Kepa JK, Winski SL, et al. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 2000;129:77–97
   PubMed Web of Science ®Google Scholar
• Nebert DW, Roe AL, Dieter MZ, et al. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000;59:65–85
   PubMed Web of Science ®Google Scholar
• Nioi P, Hayes JD. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 2004;555:149–71
   PubMed Web of Science ®Google Scholar
• Kaspar JW, Jaiswal AK. Antioxidant-induced phosphorylation of tyrosine 486 leads to rapid nuclear export of Bach1 that allows Nrf2 to bind to the antioxidant response element and activate defensive gene expression. J Biol Chem 2010;285:153–62
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13:76–86
   PubMed Web of Science ®Google Scholar
• Baird L, Lleres D, Swift S, Dinkova-Kostova AT. Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci USA 2013;110:15259–64
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002;99:11908–13
   PubMed Web of Science ®Google Scholar
• McMahon M, Lamont DJ, Beattie KA, Hayes JD. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci USA 2010;107:18838–43
   PubMed Web of Science ®Google Scholar
• Motohashi H, O’Connor T, Katsuoka F, et al. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 2002;294:1–12
   PubMed Web of Science ®Google Scholar
• Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998;17:3145–56
   PubMed Web of Science ®Google Scholar
• Cao SL, Feng YP, Jiang YY, et al. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains. Bioorg Med Chem Lett 2005;15:1915–17
   PubMed Web of Science ®Google Scholar
• Govindaraj Y, Sathyamoorthy Karthikeyan V, et al. Synthesis and in-vivo anticancer screening of 2-{[bis-(2-chloroethyl) amino] methyl} -6, 8-dinitro-1-(4-substituted ethyl)-1h-quinazolin-4-one derivatives. Acad J Cancer Res 2009;2:73–7
   Google Scholar
• Raffa D, Elder MC, Daidone G, et al. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. Eur J Med Chem 2004;39:299–304
   PubMed Web of Science ®Google Scholar
• Ho N, Harapanhalli RS, Dahman BA, et al. Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy. Bioconjug Chem 2002;13:357–64
   PubMed Web of Science ®Google Scholar
• Rajveer C, Kumaraswamy D, Sudharani S, Stephen-Rathinaraj B. Synthesis of some 6-bromo quinazolinone derivatives for their pharmacological activities. Int J Pharm Bio Sci 2010;1:1–10
   Google Scholar
• AlSaid MS, Ghorab MM, Higgins M, Dinkova-Kostova AT. NAD(P)H: quinone oxireductase 1 inducer activity of some enaminone derivatives. Biomed Res 2015;26:7–12
   Web of Science ®Google Scholar
• Ghorab MM, Higgins M, Alsaid MS, et al. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides. J Enzyme Inhib Med Chem 2014;29:840–5
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Ragab FA, Heiba HI, et al. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur J Med Chem 2015;92:682–692
   Google Scholar
• Ghorab MM, Alsaid MS, El-Gazzar MG, et al. NAD(P)H: quinone oxireductase 1 inducer activity of novel 4-aminoquinazoline derivatives. J Enzyme Inhib Med Chem 2016. [Epub ahead of print]. doi: 10.3109/14756366.2015.1135913
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Alsaid MS, Al-Dosari MS, et al. Design, synthesis and anticancer evaluation of novel quinazoline-sulfonamide hybrids. Molecules 2016;21:189–201
   Web of Science ®Google Scholar
• Gellibert F, Fouchet MH, Nguyen VL, et al. Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors. Bioorg Med Chem Lett 2009;19:2277–81
   PubMed Web of Science ®Google Scholar
• Fahey JW, Dinkova-Kostova AT, Stephenson KK, Talalay P. The “Prochaska” microtiter plate bioassay for inducers of NQO1. Meth Enzymol 2004;382:243–58
   PubMed Web of Science ®Google Scholar